Inspire Medical Systems
INSP
55.10
-1.18
-2.10%
Inspire Medical Systems
US · INSP
#2781 by market cap
Listed 2018
55.10
-1.18
-2.10%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Quant vs Street three independent views, side by side
StockVane factor grade
A-
Momentum strategy signal
Strong Sell
Analyst consensus
Hold
Signals diverge - worth digging into why.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
✦ Quant Analyst Revision Trend how this is computed
Deteriorating
1 11
■ Upgrades■ Downgrades
- 1 upgrade vs 11 downgrades among tracked analyst rating changes.
- Most recent: Evercore moved from Buy to Hold on 2026-08-04.
Analyst consensus 12 analysts
Hold
Avg price target 74.36 +35.0%
Price target rangecurrent 55.10
Low45.00
Avg74.36
High97.00
Buy 33%
Hold 50%
Sell 17%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-11-06 | UBS | -- | Sell | 45.00 |
| 2026-11-03 | Piper Sandler | -- | Hold | 70.00 |
| 2026-11-03 | KeyBanc | -- | Hold | -- |
| 2026-11-03 | Baird | -- | Hold | 77.00 |
| 2026-11-03 | Stifel | -- | Buy | 85.00 |
| 2026-11-03 | Barclays | -- | Sell | 62.00 |
| 2026-11-03 | Oppenheimer | -- | Buy | 85.00 |
| 2026-11-02 | Wells Fargo | -- | Hold | 69.00 |
| 2026-11-02 | RBC Capital | -- | Hold | 75.00 |
| 2026-10-14 | Truist Financial | -- | Hold | 78.00 |
| 2026-10-13 | Mizuho Securities | -- | Buy | 75.00 |
| 2026-10-06 | Barclays | -- | Sell | 65.00 |
| 2026-10-01 | RBC Capital | -- | Hold | 75.00 |
| 2026-09-22 | Stifel | -- | Buy | 85.00 |
| 2026-09-21 | Freedom Capital Markets | -- | Buy | 97.00 |
| 2026-09-13 | Stifel | -- | Buy | 80.00 |
| 2026-09-11 | Stifel | -- | Buy | 80.00 |
| 2026-08-04 | Wells Fargo | -- | Hold | 56.00 |
| 2026-08-04 | Mizuho Securities | -- | Buy | 65.00 |
| 2026-08-04 | Piper Sandler | -- | Hold | 60.00 |
| 2026-08-04 | KeyBanc | -- | Hold | -- |
| 2026-08-04 | BofA Securities | -- | Sell | 45.00 |
| 2026-08-04 | Truist Financial | -- | Hold | 62.00 |
| 2026-08-04 | Baird | -- | Hold | 59.00 |
| 2026-08-04 | Evercore | -- | Hold | 54.00 |
Price target trend monthly average, last 3 years
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-08-04 | Evercore | Buy → Hold | 54.00 |
| 2026-08-04 | Oppenheimer | Hold → Buy | 85.00 |
| 2026-07-28 | UBS | Hold → Sell | 39.00 |
| 2026-05-22 | BofA Securities | Hold → Sell | 39.00 |
| 2026-05-15 | BofA Securities | Buy → Hold | 53.00 |
| 2026-05-05 | Piper Sandler | Buy → Hold | 55.00 |
| 2026-02-13 | Wolfe Research | Buy → Hold | -- |
| 2026-02-12 | Baird | Buy → Hold | 74.00 |
| 2026-02-12 | Nephron | Buy → Hold | -- |
| 2026-02-11 | Wells Fargo | Buy → Hold | 70.00 |
| 2026-01-26 | RBC Capital | Buy → Hold | 90.00 |
| 2026-01-22 | Oppenheimer | Buy → Hold | -- |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q3 | 2026-11-02 | After close | ±11.87% | -7.90% (in line) |
| 2026/Q2 | 2026-08-03 | After close | ±12.35% | +22.83% (beat) |
| 2026/Q1 | 2026-05-04 | After close | ±16.13% | -12.02% (in line) |
| 2025/Q4 | 2026-02-11 | After close | ±12.14% | -12.55% (beat) |
| 2025/Q3 | 2025-11-03 | After close | ±16.18% | +15.33% (in line) |
| 2025/Q2 | 2025-08-04 | After close | ±15.60% | -32.35% (beat) |
| 2025/Q1 | 2025-05-05 | After close | ±13.25% | +1.98% (in line) |
| 2024/Q4 | 2025-02-10 | After close | ±12.41% | +1.66% (in line) |
| 2024/Q3 | 2024-11-04 | After close | ±16.06% | +3.26% (in line) |
| 2024/Q2 | 2024-08-06 | After close | ±15.05% | +28.14% (beat) |
| 2024/Q1 | 2024-05-07 | After close | ±9.36% | -33.47% (beat) |
| 2023/Q4 | 2024-02-06 | After close | ±10.11% | -10.55% (beat) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Inspire Medical Systems discussion 0 comments